Journal Watch · Cell · 2026
RNA structure programs endogenous ADAR for precise and efficient editing.
This work elucidates the structural and mechanistic principles underlying arRNA-mediated editing and establishes a framework for the rational design of highly efficient and precise A-to-I RNA-editing tools.
TL;DR
This work elucidates the structural and mechanistic principles underlying arRNA-mediated editing and establishes a framework for the rational design of highly efficient and precise A-to-I RNA-editing tools.
Key findings
- This work elucidates the structural and mechanistic principles underlying arRNA-mediated editing and establishes a framework for the rational design of highly efficient and precise A-to-I RNA-editing tools.
What they did
Here, we present LEAPER 3.0 (leveraging endogenous ADAR for programmable editing of RNA), a next-generation RNA-editing platform that integrates AlphaFold 3 structural predictions with systematic biochemical and cellular assays to define the molecular interface between ADAR1 or ADAR2 and double-stranded RNA. These insights enabled the rational optimization of arRNAs to expand the editable sequence range to previously refractory sites, suppress bystander editing within duplex regions, and achieve single-nucleotide discrimination among adjacent adenosines.
Full abstract (original)
Background: Leveraging endogenous adenosine deaminase (ADAR) enzymes through engineered ADAR-recruiting RNAs (arRNAs) offers a safe, programmable strategy for RNA editing without exogenous enzyme delivery. Yet an incomplete understanding of ADAR's mechanistic basis has hindered the rational design of arRNAs with improved efficiency and precision.
What they did: Here, we present LEAPER 3.0 (leveraging endogenous ADAR for programmable editing of RNA), a next-generation RNA-editing platform that integrates AlphaFold 3 structural predictions with systematic biochemical and cellular assays to define the molecular interface between ADAR1 or ADAR2 and double-stranded RNA. These insights enabled the rational optimization of arRNAs to expand the editable sequence range to previously refractory sites, suppress bystander editing within duplex regions, and achieve single-nucleotide discrimination among adjacent adenosines.
Results & conclusions: This work elucidates the structural and mechanistic principles underlying arRNA-mediated editing and establishes a framework for the rational design of highly efficient and precise A-to-I RNA-editing tools.
Abstract © the authors / Cell (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1016/j.cell.2026.04.047 · PubMed 42269608.
Why it matters for pharma & biotech
- Relevant to General & Medicine teams tracking Cell for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Cell study find?
This work elucidates the structural and mechanistic principles underlying arRNA-mediated editing and establishes a framework for the rational design of highly efficient and precise A-to-I RNA-editing tools.
What type of study is this?
It is a research study, published in Cell in 2026. Here, we present LEAPER 3.0 (leveraging endogenous ADAR for programmable editing of RNA), a next-generation RNA-editing platform that integrates AlphaFold 3 structural predictions with systematic biochemical and cellular assays to define the molecular interface between ADAR1 or ADAR2 and double-stranded RNA.
Where can I read the original paper?
The original is at the publisher via DOI 10.1016/j.cell.2026.04.047. PubMed ID: 42269608. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/rna-structure-programs-endogenous-adar-for-precise-and-efficient-editing-604047/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides